Matthew R. Brier

Matthew R. Brier

Auto-generated profile, based on publicly available information

Matthew R. Brier

Department of Neurology, School of Medicine Washington University in St. Louis St. Louis Missouri USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2010 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Open access
PDF file
FXFeng Xu
Feng Xu
JUJinsoo Uh
Jinsoo Uh
MBMatthew R Brier
Matthew R Brier
JHJohn Hart
John Hart
UYUma S Yezhuvath
Uma S Yezhuvath
HLHanzhang Lu
Hanzhang Lu
A better understanding of carbon dioxide (CO2) effect on brain activity may have a profound impact on clinical studies using CO2 manipulation to assess cerebrovascular reserve and on the use of hypercapnia as a means to calibrate functional magnetic resonance imaging (fMRI) signal. This study investigates how an increase in blood CO2, via inhalation of 5% CO2, may alter brain activity in humans. Dynamic measurement of brain metabolism revealed that mild hypercapnia resulted in a suppression of cerebral metabolic rate of oxygen ( CMRO 2) by 13.4%±2.3% ( N=14) and, furthermore, the CMRO 2 change was proportional to the subject's end-tidal CO2 (Et-CO2) change. When using functional connectivity MRI (fcMRI) to assess the changes in resting-state neural activity, it was found that hypercapnia resulted in a reduction in all fcMRI indices assessed including cluster volume, cross-correlation coefficient, and amplitude of the fcMRI signal in the default-mode network (DMN). The extent of the reduction was more pronounced than similar indices obtained in visual-evoked fMRI, suggesting a selective suppression effect on resting-state neural activity. Scalp electroencephalogram (EEG) studies comparing hypercapnia with normocapnia conditions showed a relative increase in low frequency power in the EEG spectra, suggesting that the brain is entering a low arousal state on CO2 inhalation.

26 March 2013 in Neurology
Verified
Journal Article
Closed access
PDF file
JTJewell B. Thomas
Jewell B. Thomas
MBMatthew R. Brier
Matthew R. Brier
ASAbraham Z. Snyder
Abraham Z. Snyder
FVFlorin F. Vaida
Florin F. Vaida
BABeau M. Ances
Beau M. Ances
Objective: Resting-state functional connectivity MRI (rs-fcMRI) may provide insight into the neurophysiology of HIV and aging. Methods: In this cross-sectional study, we used rs-fcMRI to investigate intra- and internetwork connectivity among 5 functional brain networks in 58 HIV-infected (HIV+) participants (44% receiving highly active antiretroviral therapy) and 53 HIV-uninfected (HIV−) controls. An analysis of covariance assessed the relationship among age, HIV laboratory markers, or degree of cognitive impairment and brain networks. Results: Individuals who were HIV+ had decreased rs-fcMRI intranetwork correlations in the default mode (DMN, p = 0.01), control (CON, p = 0.02), and salience (SAL, p = 0.02) networks, but showed no changes in the sensorimotor (SMN) or dorsal attention (DAN) network. Compared with HIV− controls, participants who were HIV+ had a significant loss of internetwork correlations between the DMN-DAN (p = 0.02), trending loss in DMN-SAL (p = 0.1) and CON-SMN (p = 0.1), and trending increase in CON-SAL (p = 0.1). Neither HIV markers (plasma HIV viral load or CD4+ cell count) nor degree of cognitive impairment correlated with rs-fcMRI measures. Aging correlated with a decrease in the magnitude of intranetwork functional connectivity within the DMN (p = 0.04) and SAL (p = 0.006) and with decreased magnitude of internetwork functional connectivity between DMN and SAL (p = 0.009) for both HIV+ and HIV− participants. No interaction was observed between HIV and aging. Conclusions: HIV and aging may cause independent decreases in rs-fcMRI. HIV may lead to a baseline decrease in brain function similar to deterioration that occurs with aging.

1 September 2014 in JAMA Neurology
Verified
Journal Article
Open access
PDF file
JTJewell B. Thomas
Jewell B. Thomas
MBMatthew R. Brier
Matthew R. Brier
RBRandall J. Bateman
Randall J. Bateman
ASAbraham Z. Snyder
Abraham Z. Snyder
TBTammie Benzinger
Tammie Benzinger
BABeau M. Ances
Beau M. Ances
Late-onset Alzheimer disease (LOAD) is the leading cause of dementia worldwide, currently affecting more than 18 million people.1 Alzheimer disease (AD) is defined by the pathological accumulation of tau neurofibrillary tangles and amyloid β (Aβ) plaques.2 While AD is typically polygenetic and late onset (LOAD), in a small subset of individuals, AD is inherited as an autosomal dominant (ADAD) trait, which is typically early onset and caused by monogenetic mutations in the genes encoding presenilin 1, presenilin 2, or amyloid precursor protein. These mutations are approximately 100% penetrant and cause AD by affecting Aβ cleavage and folding.3

1 July 2010 in Brain and Language
Verified
Journal Article
Closed access
AMAnd Mandy J. Maguire
And Mandy J. Maguire
MBMatthew R. Brier
Matthew R. Brier
TFThomas C. Ferree
Thomas C. Ferree

1 December 2009 in Brain and Cognition
Verified
Journal Article
Closed access
AMAnd Mandy J. Maguire
And Mandy J. Maguire
MBMatthew R. Brier
Matthew R. Brier
PMPatricia S. Moore
Patricia S. Moore
TFThomas C. Ferree
Thomas C. Ferree
DRDylan Ray
Dylan Ray
MKMichael A. Kraut
Michael A. Kraut

9 May 2012 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
LWLiang Wang
Liang Wang
CRCatherine M. Roe
Catherine M. Roe
ASAbraham Z. Snyder
Abraham Z. Snyder
MBMatthew R. Brier Bs
Matthew R. Brier Bs
JTJewell B. Thomas
Jewell B. Thomas
BABeau M. Ances
Beau M. Ances